Elsevier

Human Pathology

Volume 29, Issue 12, December 1998, Pages 1517-1523
Human Pathology

Original contribution
Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis

https://doi.org/10.1016/S0046-8177(98)90024-7Get rights and content

Abstract

Mucinous carcinomas of the breast, so-called colloid carcinomas, exhibit better prognoses than their nonmucinous breast counterparts. This biological difference exhibited by mucinous breast carcinomas prompted us to examine the relationship of mucin expression to colloid carcinoma histogenesis. We studied 50 colloid carcinomas, 50 noncolioid cancers, and 50 normal breasts by hematoxylin-eosin (H&E) and Alcian blue staining, mucin immunohistochemistry, in situ hybridization with a battery of MUC riboprobes, and ancillary digital image analysis. We observed luminal mucin in normal ducts in 80% of colloid carcinomas compared with 10% of noncolloid carcinomas and 6% of normal breasts (P < .01). In the cases of colloid carcinoma that showed mucin-filled ducts, luminal mucin was observed in 40% of the normal ducts and acini, 40% to 75% of the ducts involved by hyperplasia, atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS), respectively, and in 50% of the co-incidental areas of cysts (mucoceles), adenosis, fibroadenoma, and intraductal papilloma (P < .01). Immunohistochemistry showed that colloid carcinomas showed strong MUC2 cytoplasmic immunoreactivity and decreased MUC1 immunoreactivity compared with noncolloid carcinomas. In situ hybridization studies indicated fivefold increased MUC2 signals and twofold increased MUC5 signals within adjacent and remote normal epithelium in only the colloid carcinoma cases (P < .01; P < .05). In these cases of colloid carcinoma, these increased MUC2 and MUC5 signals were also observed in areas of hyperplasia, ADH, DCIS, and invasive carcinoma. In contrast, the noncolloid carcinomas showed fivefold increased MUC1 signals but no increases in MUC2 or MUC5. In mixed colloid/noncolloid carcinomas, the colloid areas had identical mucin expression patterns as the pure colloid carcinomas, but there was a loss of MUC2 and MUC5 expression and a gain of MUC1 expression in the noncolloid areas that was therefore identical to the pattern observed in pure noncolloid carcinoma. In this study, we conclude that the altered expression of mucin so characteristic of colloid carcinoma is also a field change present in adjacent and remote normal breast epithelium.

References (22)

  • R Holland et al.

    Ductal carcinoma in situ: A proposal for a new classification

    Semin Diagn Pathol

    (1994)
  • Cited by (54)

    • Morphological features and mucin expression profile of breast carcinomas with signet-ring cell differentiation

      2015, Pathology Research and Practice
      Citation Excerpt :

      Moreover, ER and GCDFP-15 were useful markers consistent with mammary origin expressed in most of our carcinomas with SRC differentiation. Some studies have demonstrated that mucinous carcinomas have a different secretory mucin expression profile than non-mucinous carcinomas, in particular, ductal invasive carcinomas [23,24,29–32]. The epithelial cells of mucinous carcinomas were found to strongly express MUC2 and MUC6 and sometimes MUC5AC, three of the secreted gel-forming mucins, which are infrequently expressed in invasive ductal carcinomas of no special type.

    • The pathology of breast cancer and the role of the histopathology laboratory

      2005, Clinical Oncology
      Citation Excerpt :

      Mucin genes produce a wide range of mucins; normal breast produces mucin from the Muc1 gene, a cell-membrane-bound mucin. In mucinous carcinoma, Muc2 and Muc5 genes switch to production of mucin, which is a gel-forming mucin [15]. This observation helps to explain the morphological appearances, and could also account for the good prognosis of pure mucinous carcinomas.

    View all citing articles on Scopus

    Supported by USPHS grants CA71195, CA40225, and CA01351. Dr Barsky is the recipient of an NCI Research Career Development Award.

    View full text